e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension in different interstitial lung diseases
L. Peng (Beijing, China)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session:
Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session type:
Thematic Poster Session
Number:
710
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Peng (Beijing, China). Pulmonary hypertension in different interstitial lung diseases. Eur Respir J 2012; 40: Suppl. 56, 710
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Determination of pulmonary hypertension degree in patients with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Pulmonary hypertension in chronic interstitial lung diseases},
Source: Eur Respir Rev 2013; 22: 292-301
Year: 2013
Pulmonary hypertension in chronic lung disease and hypoxia
Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018
Year: 2019
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia
Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017
Year: 2017
Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same?
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept